Article info

Download PDFPDF
MEK inhibition for low-grade serous ovarian cancer: are we there yet?

Authors

  • Mariana Scaranti Hospital Sírio-Libanês, Sao Paulo, Brazil Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, Sao Paulo, SP, Brazil PubMed articlesGoogle scholar articles
  • Maria Cecília Mathias-Machado Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, Sao Paulo, SP, Brazil PubMed articlesGoogle scholar articles
  • Christina Guo Royal Marsden NHS Foundation Trust, London, London, UK The Institute of Cancer Research, London, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Mariana Scaranti, Hospital Sírio-Libanês, Sao Paulo, SP 01308-050, Brazil; scarantimariana{at}gmail.com

Citation

Scaranti M, Mathias-Machado MC, Guo C
MEK inhibition for low-grade serous ovarian cancer: are we there yet?

Publication history

  • Received October 11, 2020
  • Accepted October 26, 2020
  • First published November 10, 2020.
Online issue publication 
February 28, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.